(-0.09%) 5 464.64 points
(0.08%) 39 145 points
(0.10%) 17 736 points
(-0.06%) $80.78
(-5.04%) $2.62
(-0.87%) $2 310.60
(-0.29%) $28.79
(3.19%) $1 017.90
(0.35%) $0.936
(0.76%) $10.68
(0.54%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers...
Stats | |
---|---|
Dagens volum | 0 |
Gjennomsnittsvolum | 1.55M |
Markedsverdi | 0.00 |
EPS | $-1.100 ( Q2 | 2022-08-05 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.24 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.443 (2.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-10-14 | Lesser Brian Andrew | Sell | 42 593 | Common Stock |
2022-10-14 | Lesser Brian Andrew | Sell | 37 500 | Stock Option (Right to Buy) |
2022-10-14 | Potts Jeannette | Sell | 37 500 | Stock Option (Right to Buy) |
2022-10-14 | Potts Jeannette | Sell | 43 958 | Common Stock |
2022-10-14 | Fanucci Marsha | Sell | 7 250 | Common Stock |
INSIDER POWER |
---|
-97.46 |
Last 97 transactions |
Buy: 1 770 820 | Sell: 4 300 300 |
Volum Korrelasjon
Forma Therapeutics Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Forma Therapeutics Korrelasjon - Valuta/Råvare
Forma Therapeutics Økonomi
Annual | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-4.21 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-4.21 |
FY | 2020 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-3.22 |
FY | 2019 |
Omsetning: | $100.56M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-3.15 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Forma Therapeutics
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc. operates as a subsidiary of Novo Nordisk A/S.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.